Coronavirus Disease 2019 (COVID-19): A Brief Report

Coronavirus Disease 2019 (COVID-19): A Brief Report

Domenico Lorenzo Urso

Severe acute respiratory syndrome (“SARS-CoV-2”, previously provisionally named “2019 novel coronavirus” or “2019-nCoV”) disease (COVID-19) in China, at the end of 2019, resulted in a large global outbreak. Among patients with pneumonia caused by SARS-CoV-2, fever is the most common symptom, followed by dry cough. Bilateral lung involvement with ground-glass opacities (GGOs) is the most common finding from computed tomography (CT) images of the chest. At present, there are no specific antiviral drugs against SARS-CoV-2 infection for potential therapy of humans. Current treatments are mainly focused on symptomatic and respiratory support in patients with COVID-19. Preventive measures are the current strategy to limit the spread of cases. The present report summarizes the point of the situation about this global emergency.

2020

SARS-CoV-2, coronavirus, Pandemic, Pneumonia, Respiratory Support

DOI: 10.7175/cmi.v14i1.1467

Clinical Management Issues

SEEd

Medicine (General)

EN